Variant report
Variant | nsv963985 |
---|---|
Chromosome Location | chr4:98690620-98710102 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr4:98687863..98690416-chr4:98692655..98695152,2 | MCF-7 | breast: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs113967444 | chr4:98690636-98690637 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs554381016 | chr4:98690666-98690667 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs559220372 | chr4:98690741-98690742 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs533000238 | chr4:98690765-98690766 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs149223513 | chr4:98690802-98690803 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs34425232 | chr4:98690815-98690816 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs140846007 | chr4:98690924-98690925 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs563661258 | chr4:98690934-98690935 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs111878066 | chr4:98691032-98691033 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs3894843 | chr4:98691038-98691039 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs554489008 | chr4:98691042-98691043 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs114286992 | chr4:98691053-98691054 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs372402965 | chr4:98691111-98691112 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs375429711 | chr4:98691113-98691114 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs536855334 | chr4:98691190-98691191 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs571951176 | chr4:98691232-98691233 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs34442422 | chr4:98691243-98691244 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs554613289 | chr4:98691252-98691253 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs144590921 | chr4:98691275-98691276 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs557501449 | chr4:98691316-98691317 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs4106941 | chr4:98691318-98691319 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
22 | rs191089062 | chr4:98691335-98691336 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs573349896 | chr4:98691341-98691342 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs140298581 | chr4:98691449-98691450 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs374772072 | chr4:98691515-98691516 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs182802947 | chr4:98691533-98691534 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs576141285 | chr4:98691547-98691548 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs577496319 | chr4:98691560-98691561 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs544899155 | chr4:98691568-98691569 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs555413540 | chr4:98691607-98691608 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs563465650 | chr4:98691612-98691613 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs530910402 | chr4:98691736-98691737 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs113058381 | chr4:98691841-98691842 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs561356400 | chr4:98691844-98691845 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs528527146 | chr4:98691856-98691857 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs546993986 | chr4:98691860-98691861 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs73834194 | chr4:98691902-98691903 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
38 | rs368896147 | chr4:98692016-98692017 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs595656 | chr4:98692079-98692080 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
40 | rs373662573 | chr4:98692108-98692109 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs550901960 | chr4:98692146-98692147 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs186557952 | chr4:98692189-98692190 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs537024217 | chr4:98692230-98692231 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs572427612 | chr4:98692242-98692243 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs546036819 | chr4:98692274-98692275 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs113440599 | chr4:98692282-98692283 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs117629405 | chr4:98692284-98692285 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs75459452 | chr4:98692325-98692326 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs552525991 | chr4:98692342-98692343 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs577534209 | chr4:98692383-98692384 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Acute lymphoblastic leukemia | 22237106 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Chordoma | 21602918 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Autism | 22495311 | CNVD |
Breast cancer | 21858162 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Gastric cancer | 21586687 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Melanoma | 18172304 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Breast cancer | 17603634 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Parkinson disease | 18923514 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Cancer | 21183584 | CNVD |
Breast cancer | 16272173 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
4q-syndrome | 17576883 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Muscular dystrophy | 21149563 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cervical cancer | 21062161 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Breast cancer | 16608533 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
Lung cancer | 19208797 | CNVD |
Wilms tumour | 21544195 | CNVD |
Breast cancer | 21785460 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Lung cancer | 18438408 | CNVD |
Cancer | 22429812 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Autism | 18414403 | CNVD |
primary effusion lymphomas | 17116491 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 17133270 | CNVD |
Esophageal adenocarcinoma | 18820669 | CNVD |
Colorectal cancer | 20459617 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Congenital anomalies of the kidney and urinary tract | 20505237 | CNVD |
Breast cancer | 17393978 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Cancer | 19907438 | CNVD |
Prostate cancer | 16573809 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Schizophrenia | 19197363 | CNVD |
Melanoma | 20688739 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Non-syndromic sensorineural hearing loss | 21293372 | CNVD |
Breast cancer | 22522925 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr4:98688600-98690800 | Weak transcription | HUVEC | blood vessel |
2 | chr4:98690800-98693200 | Enhancers | HUVEC | blood vessel |
3 | chr4:98691400-98691600 | Enhancers | Brain Germinal Matrix | brain |
4 | chr4:98691400-98691800 | Enhancers | Ganglion Eminence derived primary cultured neurospheres | brain |
5 | chr4:98691400-98692000 | Enhancers | HUES64 Cell Line | embryonic stem cell |
6 | chr4:98691600-98692000 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
7 | chr4:98691600-98692200 | Weak transcription | Brain Germinal Matrix | brain |
8 | chr4:98692200-98693000 | Enhancers | Brain Germinal Matrix | brain |
9 | chr4:98692600-98693000 | ZNF genes & repeats | Pancreas | Pancrea |
10 | chr4:98692800-98693000 | Enhancers | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
11 | chr4:98693000-98699000 | Weak transcription | Pancreas | Pancrea |
12 | chr4:98694600-98695600 | Enhancers | Dnd41 | blood |
13 | chr4:98695600-98696000 | Flanking Active TSS | Dnd41 | blood |
14 | chr4:98696000-98696800 | Enhancers | Dnd41 | blood |
15 | chr4:98699400-98699600 | ZNF genes & repeats | iPS DF 19.11 Cell Line | embryonic stem cell |
16 | chr4:98699600-98700000 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
17 | chr4:98707400-98711200 | Weak transcription | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |